The DOvEEgene test is the only test capable of making the distinction between cancer and non-cancer cells in pre- and post-menopausal women.
Endometrial and ovarian cancers account for the top 4th cause of cancer deaths in women in Canada, cervical cancer is the 16th top killer
8 women die from ovarian and endometrial cancers each day in Canada
Most ovarian and a subset of endometrial cancers (25%) are diagnosed in stage 3 and 4 when the cancer has spread due to vague/unspecific symptoms
The 5-year survival rate for ovarian and endometrial cancers diagnosed in stage 1 is close to 90% while those diagnosed in stage 4 drop to a 20% survival rate